CASP3 and breast cancer: HSYA can inhibit the metastasis-related protein matrix metalloproteinase 2 (MMP2) in MDA-MB-231 cells to inhibit the migration and invasion of breast cancer cells and can promote apoptosis of breast cancer cells by activating the caspase-3-dependent apoptosis pathway [35].